Clinical significance of the serum IL-2R level and Ga-67 scan findings in making a differential diagnosis between sarcoidosis and non-Hodgkin's lymphoma

Annals of Nuclear Medicine

Volumn 21, Issue 9, 2007, Pages 499-503

  Kita, Tamotsu ^a   Watanabe, Sadahiro ^a   Yano, Fuzuki ^a   Hayashi, Katsumi ^a   Yamamoto, Masayoshi ^a   Iwasaki, Yoshie ^a   Kosuda, Shigeru ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Malignant lymphoma; Sarcoidosis; sIL 2R

Indexed keywords

GALLIUM 67; GALLIUM CITRATE GA 67; INTERLEUKIN 2 RECEPTOR;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; LYMPHADENOPATHY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SARCOIDOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; WHOLE BODY SCINTISCANNING;

ADULT; AGED; DIAGNOSIS, DIFFERENTIAL; FEMALE; GALLIUM ISOTOPES; HUMANS; INJECTIONS, INTRAVENOUS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEOPLASM STAGING; SARCOIDOSIS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TUMOR MARKERS, BIOLOGICAL; WHOLE BODY IMAGING;

EID: 36448948002     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12149-007-0060-9     Document Type: Article

References (13)

1. A Alavi HI Palevsky 1992 Gallium-67-citrate scanning in the assessment of disease activity in sarcoidosis J Nucl Med 33 751 5
2. 67Ga scintigraphy in patients with sarcoidosis J Nucl Med 47 1571 6
3. SB Sulavik RP Spencer DA Weed HR Shapiro ST Shiue RJ Gastriotta 1990 Recognition of distinctive patterns of gallium-67 distribution in sarcoidosis J Nucl Med 31 1909 14
4. S Rothkrantz-Kos MP van Dieijen-Vosser PG Mulder M Drent 2003 Potential usefulness of inflammatory markers to monitor respiratory functional impairment in sarcoidosis Clin Chem 49 1510 7
5. JC Grutters JM Fellrath L Mulder R Janssen JM van den Bosch H van Delzen-Blad 2003 Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis: a clinical evaluation Chest 124 186 95
6. T Tsutsumi S Nagai K Imai Y Setoyama T Uchiyama T Izumi 1994 Soluble interleukin-2 receptor in blood from patients with sarcoidosis and idiopathic pulmonary fibrosis Sarcoidosis 11 102 9
7. N Keicho K Kitamura F Takaku H Yotsumoto 1990 Serum concentration of soluble interleukin-2 receptor as a sensitive parameter of disease activity in sarcoidosis Chest 98 1125 9
8. A Pforte A Brunner P Gais G Burger G Breyer M Strobel 1993 Concomitant modulation of serum-soluble interleukin-2 receptor and alveolar macrophage interleukin-2 receptor in sarcoidosis Am Rev Resp Dis 147 717 22
9. C Agostini L Trentin M Facco R Sancetta A Cerutti C Tassinari 1996 Role of IL-15, IL-2, and their receptors in the development of T cell alveolitis in pulmonary sarcoidosis J Immunology 157 910 8
10. JM Tangen AF Abrahamsen B Ostenstad J Bergheim 1990 Interleukin-2 receptor levels in non-Hodgkin's lymphoma: correlation to histological degree of malignancy and presence of constitutional symptoms Acta Oncol 29 581 3
11. LA Rubin DL Nelson 1990 The soluble interleukin-2 receptor: biology, function, and clinical application Ann Int Med 113 619 27
12. T Yoshimizu K Suga N Orihashi K Soejima T Kaneko M Kawamura 1991 The appearance of "lambda" and "panda" sign on Ga-67 scintigraphy in sarcoidosis Kaku-Igaku Jap J Nucl Med 28 1151 7
13. R Stasi L Zinzani P Galieni VM Lauta E Damasio E Dispensa 1995 Clinical implications of cytokine and soluble receptor measurements in patients with newly-diagnosed aggressive non-Hodgkin's lymphoma Eur J Haematol 54 9 17